Efficacy and tolerability of vildagliptin as first line treatment in patients with diabetes type 2 in an outpatient setting
详细信息 查看全文
- 作者：M. P. Yavropoulou ; M. Pikilidou ; K. Kotsa…
- 关键词：First line treatment of diabetes type 2 ; Vildagliptin ; DPP ; 4 inhibitors
- 刊名：Journal of Diabetes and Metabolic Disorders
- 出版年：2015
- 出版时间：December 2015
- 年：2015
- 卷：14
- 期：1
- 全文大小：584 KB
- 刊物主题：Diabetes; Metabolic Diseases; Endocrinology;
- 出版者：BioMed Central
- ISSN：2251-6581
文摘
Background Inhibitors of dipeptidyl-peptidase IV are recommended as second-line therapy in type 2 diabetes (DT2), but data, as a first-line treatment in everyday clinical practice are scarce. To address this issue we conducted a 12-month, clinical study in an outpatient setting, using vildagliptin as the first-line treatment.